Chemed (CHE) Reaches $282.92 52-Week High; Sir Capital Management LP Has Boosted Its Celanese Del (CE) Holding

March 14, 2018 - By Ellis Scott

Sir Capital Management Lp increased Celanese Corp Del (CE) stake by 14.4% reported in 2017Q3 SEC filing. Sir Capital Management Lp acquired 22,632 shares as Celanese Corp Del (CE)’s stock declined 5.81%. The Sir Capital Management Lp holds 179,829 shares with $18.75 million value, up from 157,197 last quarter. Celanese Corp Del now has $14.37B valuation. The stock decreased 1.85% or $2 during the last trading session, reaching $105.83. About 230,842 shares traded. Celanese Corporation (NYSE:CE) has risen 21.48% since March 14, 2017 and is uptrending. It has outperformed by 4.78% the S&P500.

The stock of Chemed Corporation (NYSE:CHE) hit a new 52-week high and has $294.24 target or 4.00% above today’s $282.92 share price. The 5 months bullish chart indicates low risk for the $4.57 billion company. The 1-year high was reported on Mar, 14 by If the $294.24 price target is reached, the company will be worth $182.88 million more. The stock increased 0.90% or $2.52 during the last trading session, reaching $282.92. About 65,126 shares traded. Chemed Corporation (NYSE:CHE) has risen 54.48% since March 14, 2017 and is uptrending. It has outperformed by 37.78% the S&P500.

Investors sentiment increased to 1.05 in 2017 Q3. Its up 0.14, from 0.91 in 2017Q2. It is positive, as 24 investors sold CE shares while 162 reduced holdings. 56 funds opened positions while 114 raised stakes. 126.78 million shares or 3.48% less from 131.35 million shares in 2017Q2 were reported. Ftb Advsrs Inc has invested 0% of its portfolio in Celanese Corporation (NYSE:CE). Twin Capital has invested 0.19% of its portfolio in Celanese Corporation (NYSE:CE). Fjarde Ap owns 42,829 shares or 0.09% of their US portfolio. 70,994 were accumulated by Nicholas Invest Lp. Ledyard Comml Bank holds 0% of its portfolio in Celanese Corporation (NYSE:CE) for 60 shares. World Asset Incorporated has 6,272 shares. Webster Natl Bank N A reported 0.01% stake. Natixis Asset reported 7,350 shares. State Of Wisconsin Board, Wisconsin-based fund reported 107,769 shares. Motco owns 249 shares or 0% of their US portfolio. Hsbc Public Limited Company holds 0.02% or 102,789 shares in its portfolio. Jefferies Gp Limited Liability Corporation invested in 17,932 shares. Tci Wealth Incorporated holds 0.01% of its portfolio in Celanese Corporation (NYSE:CE) for 180 shares. Evercore Wealth Mngmt Limited Company reported 504,001 shares. Alps Inc owns 4,748 shares.

Sir Capital Management Lp decreased Noble Energy Inc (NYSE:NBL) stake by 495,416 shares to 76,854 valued at $2.18M in 2017Q3. It also reduced Oneok Inc New (NYSE:OKE) stake by 118,880 shares and now owns 451,890 shares. Rpc Inc (NYSE:RES) was reduced too.

Among 17 analysts covering Celanese (NYSE:CE), 12 have Buy rating, 1 Sell and 4 Hold. Therefore 71% are positive. Celanese had 69 analyst reports since September 1, 2015 according to SRatingsIntel. Cowen & Co maintained it with “Buy” rating and $115.0 target in Tuesday, September 5 report. The stock has “Buy” rating by RBC Capital Markets on Monday, October 9. The stock of Celanese Corporation (NYSE:CE) has “Buy” rating given on Thursday, October 5 by Jefferies. Jefferies maintained Celanese Corporation (NYSE:CE) on Friday, May 26 with “Buy” rating. The rating was initiated by KeyBanc Capital Markets on Friday, October 7 with “Overweight”. RBC Capital Markets maintained Celanese Corporation (NYSE:CE) on Wednesday, October 21 with “Sector Perform” rating. Cowen & Co maintained Celanese Corporation (NYSE:CE) on Wednesday, February 15 with “Outperform” rating. SunTrust upgraded Celanese Corporation (NYSE:CE) on Monday, January 11 to “Buy” rating. Citigroup downgraded the shares of CE in report on Wednesday, September 7 to “Neutral” rating. The rating was maintained by Jefferies on Thursday, June 29 with “Buy”.

Chemed Corporation provides hospice and palliative care services in the United States. The company has market cap of $4.57 billion. It operates through two divisions, VITAS and Roto-Rooter. It has a 48.28 P/E ratio. The firm offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.

Investors sentiment decreased to 0.96 in 2017 Q3. Its down 0.08, from 1.04 in 2017Q2. It fall, as 21 investors sold Chemed Corporation shares while 80 reduced holdings. 29 funds opened positions while 76 raised stakes. 15.40 million shares or 0.81% more from 15.27 million shares in 2017Q2 were reported. Gamco Invsts Et Al stated it has 527,204 shares. New York-based Alliancebernstein Lp has invested 0.01% in Chemed Corporation (NYSE:CHE). Gotham Asset Mgmt Llc owns 18,034 shares. Ohio-based Bahl And Gaynor has invested 0.03% in Chemed Corporation (NYSE:CHE). California Employees Retirement Systems reported 0.02% stake. Bnp Paribas Arbitrage Sa has invested 0% in Chemed Corporation (NYSE:CHE). Wellington Grp Incorporated Llp invested in 54,035 shares. Ny State Teachers Retirement reported 40,658 shares. Systematic Management L P reported 7,860 shares. Rhumbline Advisers accumulated 50,493 shares. Acadian Asset Mngmt reported 570,950 shares stake. South Dakota Invest Council stated it has 5,000 shares or 0.02% of all its holdings. Tompkins Fincl Corp holds 0.03% or 607 shares. Northern Corporation invested in 0.01% or 247,003 shares. 2,000 are held by At Fincl Bank.

Since October 2, 2017, it had 0 insider buys, and 6 selling transactions for $4.44 million activity. On Thursday, March 1 the insider MCNAMARA KEVIN J sold $1.55 million. GRACE PATRICK P also sold $100,740 worth of Chemed Corporation (NYSE:CHE) shares. $166,568 worth of Chemed Corporation (NYSE:CHE) was sold by Dallob Naomi C. SAUNDERS DONALD E also sold $117,485 worth of Chemed Corporation (NYSE:CHE) shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: